Loading…
Loading…
AGT (iShares MSCI Argentina and Global Exposure ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Kardiganâ¢, Inc. (Nasdaq: KARD) (âKardiganâ or âthe Companyâ), a clinical-stage precision therapeutics company developing medicines that target the roo
AGT Food and Ingredients Inc. (AGTF:CA) Shareholder/Analyst Call Transcript
LONDON, May 14, 2026 - (ACN Newswire) - Asset Value Investors Limited ("AVI") has submitted shareholder proposals on one of AVI Japan Opportunity Trust's ("AJOT
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (the "Company") announces that the Company's auditors, AGT Partners LLP ("AGT"), have withdrawn and resigned as auditor of the Company, effective April 6, 2026, and will not complete the audit or issue an auditor's report on the Company's financial statements for the year ended December 31, 2025. AGT has advised that its withdrawal and resignation relate to a previously identified and publicly disclosed governance and internal control weakness relating to United States sales tax compliance, which, in AGT's professional judgment, remains in the process of remediation and informed AGT's decision not to continue as auditor or complete the audit.
REGINA, Saskatchewan, Nov. 20, 2024 (GLOBE NEWSWIRE) -- AGT Food and Ingredients Inc. (“AGT”) is pleased to announce the sale of all shares of AGT's shortline rail and bulk handling infrastructure, comprising Mobil Grain Ltd., (“MobilGrain”) to GCM Grosvenor (NASDAQ: GCMG), a global alternative asset management firm, through the firm's Infrastructure Advantage Strategy. Financial terms and details of the sale and subsequent agreement have not been disclosed. Northborne Partners acted as the sole lead advisor to AGT on the transaction.
SAN FRANSCISO and SUZHOU, China , Aug. 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, and Sanegene Bio USA Inc. (SanegeneBio) today announced the first participant has been successfully dosed in a Phase 1 First-in-Human (FIH) clinical trial of IBI3016. IBI3016 (SanegeneBio's R&D code: SGB-3908) is an siRNA drug candidate targeting angiotensinogen (AGT) for the treatment of hypertension.
Argentina's official election isn't until October. However, Libertarian economist Javier Milei's big upset in the August primary suggests the South American country could soon have a new president.
The MSCI Latin America Index has performed better than the MSCI Emerging Market Index cumulatively over the past 5 and 7 years as well as over longer time periods, buoyed by its natural resource companies. The region is well placed to take advantage of the opportunities created by the renewable energy revolution with 54% of global lithium reserves concentrated there.